Posts by: admin

News

During the European Cancer Congress, Vienna, Austria, Genentech announced positive results from two Phase II studies of atezolizumab in patients with advanced non-small cell lung cancer (NSCLC). Atezolizumab was effective in ... Read more

October 2, 2015October 4, 2015

Genentech Presents Positive Results of Atezolizumab in Advanced Bladder Cancer

News

Genentech recently announced results from a Phase II study, IMvigor 210, during the 2015 European Cancer Congress, Vienna, Austria. The trial assessed the use of investigational cancer immunotherapy atezolizumab in individuals with advanced urothelial carcinoma. ... Read more

February 24, 2015February 24, 2015

New Clinical Trial for Glioblastoma Treatment Uses Immunotherapy

News

A research team at the Penn Medicine medical center of the University of Pennsylvania together with Novartis Institutes for Bio Medical Research recently designed a new clinical trial for ... Read more

February 18, 2015February 19, 2015

Novel Cell Therapy Targets Prostate Cancer Stem Cells

News

Researchers at the Peking Union Medical College and the Chinese Academy of Medical Sciences tested a new cellular therapy against prostate cancer. The study entitled “Adoptive T-cell therapy of ... Read more

February 13, 2015February 13, 2015

3D Vaccine Boosts Immune System Against Tumors

News

A research team led by David J. Mooney of the University of Harvard developed a 3D-structure formulation that triggers the immune system to fight tumors. The study, entitled “Injectable, ... Read more

February 10, 2015February 10, 2015

Cryoablation Combined With Intra-tumoral Injection of Immunotherapeutic Drugs Offers Promising Outcomes

News

According to researchers at Image Guided Cancer Specialists, cryoablation can efficiently treat several types of cancer, destroying tumors from the inside out and resulting in minimal scarring. Importantly, when ... Read more

February 6, 2015

Novel Assay To Identify Effective Immune Therapies In Lung Cancer Patients

News

In a recent study titled “Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer” and published in the Journal of the National Cancer Institute, a research team ... Read more

February 3, 2015February 3, 2015

Immunotherapy Found To Enhance CD4 T Cell Responses In Tumor Microenvironment

News

In a recent study, titled “Cancer Immunotherapy Employing an Innovative Strategy to Enhance CD4+ T Cell Help in the Tumor Microenvironment”, published in PlosOne, a research team from Johns ... Read more

February 2, 2015February 2, 2015

MicroConstants China Gains Global Rights of AA98 Antibody Drug Candidates

News

MicroConstants China Inc., has announced it gained the global rights from the Institute of Biophysics (IBP), Chinese Academy of Sciences (CAS) to develop AA98 antibody drug candidates that can be used ... Read more

January 30, 2015January 30, 2015

Study Identifies Novel PAD4 Inhibitors

News

In a recent study titled “Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation”, published in Nature Chemical Biology, an international team of researchers has ... Read more

Posts by: admin

admin

Atezolizumab Shows Benefits in Two Lung Cancer Studies

Genentech Presents Positive Results of Atezolizumab in Advanced Bladder Cancer

New Clinical Trial for Glioblastoma Treatment Uses Immunotherapy

Novel Cell Therapy Targets Prostate Cancer Stem Cells

3D Vaccine Boosts Immune System Against Tumors

Cryoablation Combined With Intra-tumoral Injection of Immunotherapeutic Drugs Offers Promising Outcomes

Novel Assay To Identify Effective Immune Therapies In Lung Cancer Patients

Immunotherapy Found To Enhance CD4 T Cell Responses In Tumor Microenvironment

MicroConstants China Gains Global Rights of AA98 Antibody Drug Candidates

Study Identifies Novel PAD4 Inhibitors

Pin It on Pinterest